Literature DB >> 12586475

Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches?

Anne Charlotte Grüner1, Georges Snounou, Karima Brahimi, Franck Letourneur, Laurent Rénia, Pierre Druilhe.   

Abstract

A growing number of Plasmodium genomes have joined the sequencing treadmill, and the genome of Plasmodium falciparum has recently been published. Most malaria vaccinologists will soon be confronted by a bewildering array of new potential antigens from the recently completed genome of this parasite. However, for those aiming to target the pre-erythrocytic stages of the hepatic parasite, the wait might be long. In the absence of readily available materials and specific reagents, the selection of pre-erythrocytic antigens from raw sequence data is likely to prove difficult. Here, current knowledge of pre-erythrocytic antigens is updated in the light of recent results, and the post-genomic prospects of completing the antigenic repertoire of these immunologically important and intriguing stages is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586475     DOI: 10.1016/s1471-4922(02)00067-3

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  8 in total

1.  Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle.

Authors:  Myriam Bodescot; Olivier Silvie; Anthony Siau; Philippe Refour; Paco Pino; Jean-François Franetich; Laurent Hannoun; Robert Sauerwein; Dominique Mazier
Journal:  Parasitol Res       Date:  2004-02-12       Impact factor: 2.289

2.  Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.

Authors:  Marjorie Mauduit; Rita Tewari; Nadya Depinay; Michèle Kayibanda; Eliette Lallemand; Jean-Marc Chavatte; Georges Snounou; Laurent Rénia; Anne Charlotte Grüner
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

3.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Authors:  Amanda Maestre; Carlos Muskus; Victoria Duque; Olga Agudelo; Pu Liu; Akihide Takagi; Francis B Ntumngia; John H Adams; Kim Lee Sim; Stephen L Hoffman; Giampietro Corradin; Ivan D Velez; Ruobing Wang
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

5.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

Review 7.  Novel approaches to identify protective malaria vaccine candidates.

Authors:  Wan Ni Chia; Yun Shan Goh; Laurent Rénia
Journal:  Front Microbiol       Date:  2014-11-17       Impact factor: 5.640

8.  Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density.

Authors:  Ellie Sherrard-Smith; Katarzyna A Sala; Azra C Ghani; Thomas S Churcher; Andrew M Blagborough; Michael Betancourt; Leanna M Upton; Fiona Angrisano; Merribeth J Morin
Journal:  Elife       Date:  2018-06-19       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.